CD40LG and hyperinsulinemic hypoglycemia, familial, 4: Jacobsohn et al. reported on the use of non-myeloablative conditioning (fludarabine 180 mg/m2; busulfan 6.4 mg/kg; horse ATG 160 mg/kg) in two unrelated patients with CD40L deficiency and cholangiopathy (53).